Hormone Therapy 101: A Patient Guide

Hormone therapy has one of the most confusing reputations in medicine. Many women I see still associate it with a single, controversial early-2000s study — and are surprised to learn how much the guidance has changed since then, including a major update from the FDA in the last year. This guide is meant to give you the real, current picture so you can have an informed conversation with your physician, not to tell you what to do.

two vials sitting on a counter

What Hormone Therapy Actually Is

Menopausal hormone therapy (HT) replaces hormones — primarily estrogen, often paired with progesterone if you still have a uterus — that decline during perimenopause and menopause. It's most commonly prescribed for:

• Vasomotor symptoms: hot flashes and night sweats

• Genitourinary syndrome of menopause (GSM): vaginal dryness, discomfort, and related urinary symptoms

• Bone protection: reducing bone loss and fracture risk in appropriate candidates

It comes in several forms — oral pills, transdermal patches, gels, and vaginal preparations — and the route matters. Transdermal (through-the-skin) estrogen, for example, carries a different risk profile for blood clots than oral estrogen, which is one of many individualized factors your physician should walk through with you.

The "Window of Opportunity" — What Current Guidance Actually Says

The Menopause Society's position, echoed by organizations including ACOG and the Endocrine Society, is that for most healthy, symptomatic women who are younger than 60 or within 10 years of menopause onset and have no contraindications, the benefits of hormone therapy for treating menopausal symptoms outweigh the risks. Outside that window — starting more than 10 years after menopause, or after age 60 — the risk-benefit balance shifts, with greater absolute risks of heart disease, stroke, blood clots, and dementia associated with starting later.

This "timing hypothesis" is one of the most important developments in how hormone therapy is understood today, and it's a major reason blanket statements like "HRT is dangerous" or "HRT is completely safe" both miss the point. Timing, individual risk factors, formulation, and route all matter.

What Changed in Late 2025

In November 2025, the FDA began the process of removing the boxed warning about breast cancer, cardiovascular disease, and dementia risk that had been on hormone therapy labels for over two decades — a warning that many clinicians and researchers had come to view as outdated and disproportionate to the actual risk for most appropriate candidates. This doesn't mean hormone therapy is risk-free; it means the labeling is being updated to better reflect current evidence and give women more balanced, accurate information to make decisions with their physicians.

Who Generally Isn't a Candidate

Hormone therapy isn't right for everyone. It's typically avoided in women with a personal history of estrogen-sensitive breast or endometrial cancer, active or prior blood clots, stroke, coronary artery disease, active liver disease, or unexplained vaginal bleeding that hasn't been evaluated. This is exactly why a real medical history and physical exam — not a quiz or an online questionnaire — has to come before any prescription.

Common Questions I Get in the Exam Room

"Will hormone therapy make me gain weight?" No good evidence supports this. Weight changes around menopause are much more directly tied to declining muscle mass, insulin sensitivity, and fat redistribution than to hormone therapy itself — the very physiology we cover in our metabolism post.

"Is bioidentical hormone therapy safer than 'synthetic'?" "Bioidentical" refers to hormones structurally identical to what your body produces, and FDA-approved bioidentical options exist in standard pharmacy formulations. Compounded bioidentical preparations, by contrast, aren't FDA-regulated for purity, potency, or consistency the way approved products are — this distinction matters and is worth discussing directly with your physician rather than assuming "bioidentical" and "compounded" mean the same thing.

"How long can I stay on it?" Current guidance doesn't set an arbitrary stop date. Duration is individualized, based on ongoing symptoms, risk factors, and periodic reevaluation with your physician — not a fixed one- or two-year rule.

The Bottom Line

Hormone therapy is neither the villain nor the miracle it's sometimes made out to be online. It's a tool — a genuinely effective one for the right candidate — that deserves an unhurried conversation grounded in your actual history and risk factors, not a five-minute checkbox visit.

If you're navigating hot flashes, sleep disruption, or other menopausal symptoms and want a real conversation about whether hormone therapy fits your picture, learn more about our approach at attunedirectcare.com or schedule a visit if you're in Texas, Florida, Oklahoma, or Louisiana.

General wellness education only. Not medical advice. Does not establish a physician-patient relationship. Decisions about hormone therapy should be made individually with your physician based on your complete medical history.